NCT07583186
Maternal Intake of Eggs and Infant Neurodevelopment
Recruiting
NAAges 18+InterventionalUniversity of Kansas Medical CenterInvestigator-initiated
~100 participants
Updated 2026-05-13 on ClinicalTrials.gov
What's tested:Egg SupplementationHealthy Prenatal Diet
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fetal neurodevelopment as indexed by heart rate variability (HRV)
Measured over 36 weeks gestational age
Conditions
Where it's being run
1 sites across 1 statesKansas1
Study leadership
- Danielle Christifano, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Pregnant females ≥18 years of age
12 to 20-weeks' gestation at enrollment
No serious illnesses likely to confound study outcomes
Consuming 3 eggs/week or less at enrollment and willing to increase consumption during the study
Singleton gestation
Available by telephone and text
Exclusion
Less than 18 years at enrollment
Gestational age at enrollment \<12 or \>20 weeks
Any serious illness likely to confound study outcomes
Consuming more than 3 eggs per week at enrollment
Unable/unwilling to consume eggs until delivery or egg allergy
Expecting multiple infants
No access to telephone or text
What this trial measures
- Fetal neurodevelopment as indexed by heart rate variability (HRV)36 weeks gestational age
Group comparisons will be made between time-domain metrics of fetal HRV (SDNN, RMSSD) between those in EEG vs. HPD groups using a dedicated fetal heart rate monitor.